Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period
- PMID: 11877330
- PMCID: PMC1573241
- DOI: 10.1038/sj.bjp.0704577
Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period
Abstract
1. Mild stress plus mild pain (solvent injection) applied daily to neonatal mice induces hormonal, behavioural and metabolic changes perduring in the adult life. 2. We investigated whether daily mild stress to neonatal mice induces also long-term defined changes of immune response, and whether immune changes are prevented through repeated administration of the opioid antagonist naloxone. 3. Mild stress plus solvent injection administered from birth to the 21st postnatal day causes not only behavioural and metabolic changes, but also long-term (up to 110 days of life) splenocytes modifications, consisting in: increased release of the Th-1 type cytokines interleukin-2 (IL-2) (from an average of 346 to 788 pg ml(-1)), interferon-gamma (from 1770 to 3942) and tumour necrosis factor-alpha (from 760 to 1241); decreased release of the Th-2 type cytokines IL-4 (from 49.1 to 28.4) and IL-10 (from 1508 to 877). Moreover, enhanced natural killer-cell activity; enhanced proliferative splenocytes properties in resting conditions and following phytohemoagglutinin and concanavalin-A stimulation are observed. Immunological, behavioural and metabolic changes are prevented by the opioid antagonist (-)naloxone (1 mg kg(-1) per day s.c., administered instead of solvent) but not by the biologically inactive enantiomorph (+)naloxone. 4. In conclusion, endogenous opioid systems sensitive to naloxone are involved in long-lasting enhancement of the Th-1 type cytokines and cell-mediated immunological response caused by repeated mild stress administered postnatally.
Figures


Similar articles
-
The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in BALB/cJ mice.Blood. 2000 Mar 15;95(6):2031-6. Blood. 2000. PMID: 10706871
-
Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist.Neuroimmunomodulation. 2000;7(1):6-15. doi: 10.1159/000026415. Neuroimmunomodulation. 2000. PMID: 10601814
-
Effects of neonatal treatment with Tyr-MIF-1 and naloxone on the long-term body weight gain induced by repeated postnatal stressful stimuli.Peptides. 1999 Dec;20(12):1425-30. doi: 10.1016/s0196-9781(99)00152-7. Peptides. 1999. PMID: 10698117
-
Experimental evidence for immunomodulatory effects of opioids.Adv Exp Med Biol. 2003;521:106-16. Adv Exp Med Biol. 2003. PMID: 12617569 Review. No abstract available.
-
Etiopathogenesis and Pharmacological Prevention of a Type-2 Diabetes Model in Male Mice.J Pharmacol Exp Ther. 2018 Mar;364(2):347-358. doi: 10.1124/jpet.117.244707. Epub 2017 Nov 21. J Pharmacol Exp Ther. 2018. PMID: 29162628 Review.
Cited by
-
Naloxone Diminishes the Virulence and Modifies the Cellular Immune Responses of BALB/c Mice Infected with Leishmania major.Acta Parasitol. 2021 Jun;66(2):517-523. doi: 10.1007/s11686-020-00308-w. Epub 2020 Nov 19. Acta Parasitol. 2021. PMID: 33211271
-
Effect of Intermittent and Mild Cold Stimulation on the Immune Function of Bursa in Broilers.Animals (Basel). 2020 Jul 26;10(8):1275. doi: 10.3390/ani10081275. Animals (Basel). 2020. PMID: 32722590 Free PMC article.
-
Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats.Gut. 2004 Apr;53(4):501-6. doi: 10.1136/gut.2003.024174. Gut. 2004. PMID: 15016743 Free PMC article.
-
Stress in the adult rat exacerbates muscle pain induced by early-life stress.Biol Psychiatry. 2013 Nov 1;74(9):688-95. doi: 10.1016/j.biopsych.2013.04.006. Epub 2013 May 21. Biol Psychiatry. 2013. PMID: 23706525 Free PMC article.
-
Exploring the possible mechanism of low-dose naloxone exposure improving the immune microenvironment of gastric cancer tumors.Front Immunol. 2025 Mar 26;16:1524930. doi: 10.3389/fimmu.2025.1524930. eCollection 2025. Front Immunol. 2025. PMID: 40207224 Free PMC article.
References
-
- AGARWAL S.K., MARSHALL G.D., JR Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J. Interferon Cytokine Res. 2001;21:147–155. - PubMed
-
- AKIL H.A., MORANO M.I.Stres Psychopharmacology. The Fourth Generation of Progress 1995NY: Raven Press; 773–786.Bloom, F.E., Kupfer, D.J. ed
-
- ANAND K.J. Effects of perinatal pain and stress. Progr. Brain Res. 2000;122:117–129. - PubMed
-
- BELKOWSKI S.M., ALICEA C., EISENSTEIN T.K., ADLER M.W., ROGERS T.J. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H. J. Pharmacol. Exp. Ther. 1995;273:1491–1496. - PubMed
-
- BUCKETT W.R. Circadian and seasonal rhythm in stimulation-produced analgesia. Experientia. 1981;37:878–879. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources